Research · Sep 3, 2026
GOVX: FY25 Deep Dive
GeoVax Labs FY25 at $2M. NI $-21M; EPS $-22.40.
GOVX
GeoVax Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.48
−4.68%Research · Aug 25, 2026
Vaccine Procurement Shifts From Outbreak Awards to Standing Budgets
Bavarian Nordic, SIGA, Emergent and Valneva told August 2026 calls that sovereign and multilateral budgets, not outbreak awards, now drive vaccine orders.